Monmouthshire mum says she may have avoided ovarian cancer if she lived in England

Key Points:

• Heather Morgan, diagnosed with breast cancer in Wales in 2014, missed out on genetic testing available in England at the time, which could have identified her BRCA1 mutation and led to preventive measures against ovarian cancer.
• Wales only aligned its genetic testing policies with England in 2015, after Heather had completed treatment, highlighting a postcode lottery in healthcare access for hereditary cancer risk assessment.
• The National Hereditary Breast Cancer Helpline emphasizes ongoing disparities in genetic testing and cancer screening access across UK regions, with patients experiencing inconsistent eligibility criteria even within England.
• Women with BRCA1 and BRCA2 gene mutations face significantly higher lifetime risks of breast and ovarian cancers, and NICE guidelines recommend enhanced screening protocols, including annual MRIs starting from age 30.
• Conflicting advice and reduced MRI accuracy during breastfeeding complicate screening decisions for high-risk women in Wales, as illustrated by Louise Owen’s experience, underscoring the need for clearer, consistent guidance.